Progestin-containing IUDs are increasingly used for endometrial protection in patients on estrogen therapy or with specific gynecologic risks—but what does the data actually support? In this focused session, Dr. Amy Voedisch will review the evidence behind progestin IUD use for endometrial protection, including patient selection, duration of use, and clinical scenarios where they offer advantages over systemic progestins. Attendees will gain practical strategies for integrating this approach into menopause care and beyond.

Amy Voedisch, MD, MSCP, is a board-certified OB/GYN and Complex Family Planning specialist, as well as a certified menopause practitioner through The Menopause Society. She serves as a Clinical Associate Professor in the Department of Obstetrics and Gynecology at Stanford University School of Medicine.

Dr. Voedisch received her undergraduate degree from Macalester College and earned her medical degree from Mayo Medical School. She completed her OB/GYN residency at Kaiser Permanente Santa Clara, followed by a fellowship in Complex Family Planning and a master’s in Epidemiology and Clinical Research at Stanford.

Her clinical practice focuses on comprehensive reproductive healthcare, with expertise in contraception, abortion care, perimenopause, and menopause. She is deeply committed to global health and serves as a consultant with the Stanford Program for International Reproductive Education and Services (SPIRES), providing training and quality assurance in family planning worldwide.

Grounded in a patient-centered philosophy, Dr. Voedisch emphasizes shared decision-making and individualized care to support women at every stage of life.